HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cereal Firm Post Expands Into Supplements With Premier Nutrition Pick-Up

This article was originally published in The Tan Sheet

Executive Summary

Seeking to diversify its portfolio for more dramatic sales growth, Post Holdings acquires Premier Nutrition, maker of Joint Juice and Premier Protein supplements. The $180 million transaction follows closely Post’s purchase of probiotic bar and natural cereal maker Attune Foods.

You may also be interested in...



Garden Of Life Blooms For Atrium During M&A Break

After more than a dozen acquisitions between 2000 and 2010, Atrium Innovations is on hiatus from M&A activity to focus on integrating operations and driving growth in its branded retail sales, led by subsidiary Garden of Life.

In Brief

HHS OIG to scrutinize supplement claims

Joint Juice Flows Toward Dietary Supplement Industry

Joint Juice, the 10-year-old maker of eponymous liquid joint health products, has a new CEO and a newfound commitment to the supplement industry.

Topics

Related Companies

UsernamePublicRestriction

Register

RS124190

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel